How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 60 (12) , 1205-1219
- https://doi.org/10.1016/j.jclinepi.2007.04.020
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian CancerJNCI Journal of the National Cancer Institute, 2005
- Bias as a threat to the validity of cancer molecular-marker researchNature Reviews Cancer, 2005
- Rules of evidence for cancer molecular-marker discovery and validationNature Reviews Cancer, 2004
- Detection of cancer-specific markers amid massive mass spectral dataProceedings of the National Academy of Sciences, 2003
- DNA microarrays in breast cancer: the promise of personalised medicineThe Lancet, 2003
- Gene expression predictors of breast cancer outcomesThe Lancet, 2003
- Developing Molecular Biomarkers for CancerScience, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Metastasis genes: A progression puzzleNature, 2002
- Use of proteomic patterns in serum to identify ovarian cancerPublished by Elsevier ,2002